{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:45Z","timestamp":1772165685101,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China Grant","doi-asserted-by":"crossref","award":["81871354"],"award-info":[{"award-number":["81871354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Academic Promotion Program of Shandong First Medical University","award":["2019QL023"],"award-info":[{"award-number":["2019QL023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To establish and verify a radiomics nomogram for differentiating isolated micronodular adrenal hyperplasia (iMAD) from lipid-poor adenoma (LPA) based on computed tomography (CT)-extracted radiomic features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 148 patients with iMAD or LPA were divided into three cohorts: a training cohort (n\u2009=\u200972; 37 iMAD and 35 LPA), a validation cohort (n\u2009=\u200936; 22 iMAD and 14 LPA), and an external validation cohort (n\u2009=\u200940; 20 iMAD and 20 LPA). Radiomics features were extracted from contrast-enhanced and non-contrast CT images. The least absolute shrinkage and selection operator (LASSO) method was applied to develop a triphasic radiomics model and unenhanced radiomics model using reproducible radiomics features. A clinical model was constructed using certain laboratory variables and CT findings. Radiomics nomogram was established by selected radiomics signature and clinical factors. Nomogram performance was assessed by calibration curve, the areas under receiver operating characteristic curves (AUC), and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven and eight extracted features were finally selected to construct an unenhanced radiomics model and a triphasic radiomics model, respectively. There was no significant difference in AUC between the two models in the external validation cohort (0.838 vs. 0.843,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.949). The radiomics nomogram inclusive of the unenhanced model, maximum diameter, and aldosterone showed the AUC of 0.951, 0.938, and 0.893 for the training, validation, and external validation cohorts, respectively. The nomogram showed good calibration, and the DCA demonstrated the superiority of the nomogram compared with the clinical factors model alone in terms of clinical usefulness.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A radiomics nomogram based on unenhanced CT images and clinical variables showed favorable performance for distinguishing iMAD from LPA. In addition, an efficient unenhanced model can help avoid extra contrast-enhanced scanning and radiation risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-022-00951-x","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T10:24:35Z","timestamp":1673087075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CT-based radiomics nomogram for differentiation of adrenal hyperplasia from lipid-poor adenoma: an exploratory study"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongtao","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songnan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congshan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"issue":"5","key":"951_CR1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2214\/AJR.13.11389","volume":"202","author":"JM Seo","year":"2014","unstructured":"Seo JM, Park BK, Park SY, et al. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol. 2014;202(5):1043\u201350.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"951_CR2","first-page":"1333","volume":"29","author":"P Johnson","year":"2009","unstructured":"Johnson P, Horton K, Fishman E. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiogr Rev Publ Radiol Soc N Am. 2009;29(5):1333\u201351.","journal-title":"Radiogr Rev Publ Radiol Soc N Am"},{"issue":"4","key":"951_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00261-019-02215-9","volume":"45","author":"MG Elbanan","year":"2020","unstructured":"Elbanan MG, Javadi S, Ganeshan D, et al. Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics. Abdom Radiol (NY). 2020;45(4):905\u201316.","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"951_CR4","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"JH Song","year":"2008","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"951_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4103\/2230-8210.100659","volume":"16","author":"V Chaudhary","year":"2012","unstructured":"Chaudhary V, Bano S. Anatomical and functional imaging in endocrine hypertension. Indian J Endocrinol Metab. 2012;16(5):713\u201321.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"951_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/2230-8210.146858","volume":"19","author":"A Panda","year":"2015","unstructured":"Panda A, Das CJ, Dhamija E, et al. Adrenal imaging (part 1): imaging techniques and primary cortical lesions. Indian J Endocrinol Metab. 2015;19(1):8\u201315.","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"951_CR7","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","volume":"34","author":"I Bourdeau","year":"2020","unstructured":"Bourdeau I, Parisien-La Salle S, Lacroix A. Adrenocortical hyperplasia: a multifaceted disease. Best Pract Res Clin Endocrinol Metab. 2020;34(3):101386.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"951_CR8","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/biomedicines9101397","volume":"9","author":"B Chevalier","year":"2021","unstructured":"Chevalier B, Vantyghem MC, Espiard S. Bilateral adrenal hyperplasia: pathogenesis and treatment. Biomedicines. 2021;9(10):1397.","journal-title":"Biomedicines"},{"issue":"8","key":"951_CR9","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00261-017-1429-4","volume":"43","author":"V Romeo","year":"2018","unstructured":"Romeo V, Maurea S, Guarino S, et al. The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results. Abdom Radiol (NY). 2018;43(8):2119\u201329.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"951_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4158\/EP12277.RA","volume":"19","author":"A Maghrabi","year":"2013","unstructured":"Maghrabi A, Yaqub A, Denning KL, et al. Challenges in the diagnostic work-up and management of patients with subclinical Cushing\u2019s syndrome and bilateral adrenal masses. Endocr Pract. 2013;19(3):515\u201321.","journal-title":"Endocr Pract"},{"issue":"12","key":"951_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","volume":"9","author":"M Reincke","year":"2021","unstructured":"Reincke M, Bancos I, Mulatero P, et al. Diagnosis and treatment of primary aldosteronism. Lancet Diabetes Endocrinol. 2021;9(12):876\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"951_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2214\/AJR.15.14558","volume":"206","author":"SY Park","year":"2016","unstructured":"Park SY, Park BK, Park JJ, et al. Differentiation of adrenal hyperplasia from adenoma by use of CT densitometry and percentage washout. AJR Am J Roentgenol. 2016;206(1):106\u201312.","journal-title":"AJR Am J Roentgenol"},{"key":"951_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1172-5-9","volume":"5","author":"L Amar","year":"2010","unstructured":"Amar L, Plouin P, Steichen O. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis. 2010;5:9.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"951_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diabet.2019.10.002","volume":"46","author":"H Komada","year":"2020","unstructured":"Komada H, Hirota Y, So A, et al. Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma. Diabetes Metab. 2020;46(3):236\u201342.","journal-title":"Diabetes Metab"},{"issue":"2","key":"951_CR15","doi-asserted-by":"publisher","first-page":"101365","DOI":"10.1016\/j.beem.2019.101365","volume":"34","author":"Y Yang","year":"2020","unstructured":"Yang Y, Reincke M, Williams TA. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101365.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"951_CR16","doi-asserted-by":"publisher","first-page":"101486","DOI":"10.1016\/j.beem.2021.101486","volume":"35","author":"L Meloche-Dumas","year":"2021","unstructured":"Meloche-Dumas L, Mercier F, Lacroix A. Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab. 2021;35(2):101486.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7\u20138","key":"951_CR17","first-page":"565","volume":"24","author":"M Kumorowicz-Czoch","year":"2011","unstructured":"Kumorowicz-Czoch M, Dolezal-Oltarzewska K, Roztoczynska D, et al. Causes and consequences of abandoning one-stage bilateral adrenalectomy recommended in primary pigmented nodular adrenocortical disease\u2013case presentation. J Pediatr Endocrinol Metab. 2011;24(7\u20138):565\u20137.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"951_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/HJH.0000000000002634","volume":"39","author":"D Ma","year":"2021","unstructured":"Ma D, Liu X, Zeng L, et al. The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism. J Hypertens. 2021;39(2):310\u20137.","journal-title":"J Hypertens"},{"issue":"2","key":"951_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"R Gillies","year":"2016","unstructured":"Gillies R, Kinahan P, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"12","key":"951_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"951_CR21","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/RCT.0000000000001051","volume":"44","author":"H Yu","year":"2020","unstructured":"Yu H, Parakh A, Blake M, et al. Texture analysis as a radiomic marker for differentiating benign from malignant adrenal tumors. J Comput Assist Tomogr. 2020;44(5):766\u201371.","journal-title":"J Comput Assist Tomogr"},{"issue":"4","key":"951_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s13167-018-0149-3","volume":"9","author":"X Yi","year":"2018","unstructured":"Yi X, Guan X, Zhang Y, et al. Radiomics improves efficiency for differentiating subclinical pheochromocytoma from lipid-poor adenoma: a predictive, preventive and personalized medical approach in adrenal incidentalomas. EPMA J. 2018;9(4):421\u20139.","journal-title":"EPMA J"},{"issue":"1","key":"951_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-022-03233-w","volume":"20","author":"J Kong","year":"2022","unstructured":"Kong J, Zheng J, Wu J, et al. Development of a radiomics model to diagnose pheochromocytoma preoperatively: a multicenter study with prospective validation. J Transl Med. 2022;20(1):31.","journal-title":"J Transl Med"},{"issue":"10","key":"951_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.diii.2020.09.001","volume":"101","author":"M Benchoufi","year":"2020","unstructured":"Benchoufi M, Matzner-Lober E, Molinari N, et al. Interobserver agreement issues in radiology. Diagn Interv Imaging. 2020;101(10):639\u201341.","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"951_CR25","doi-asserted-by":"publisher","first-page":"zraa061","DOI":"10.1093\/bjsopen\/zraa061","volume":"5","author":"F Torresan","year":"2021","unstructured":"Torresan F, Crimi F, Ceccato F, et al. Radiomics: a new tool to differentiate adrenocortical adenoma from carcinoma. BJS Open. 2021;5(1):zraa061.","journal-title":"BJS Open"},{"issue":"3","key":"951_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40618-019-01114-6","volume":"43","author":"HT Leung","year":"2020","unstructured":"Leung HT, Woo YC, Fong CHY, et al. A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia. J Endocrinol Invest. 2020;43(3):347\u201355.","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"951_CR27","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","volume":"85","author":"P Jl","year":"2000","unstructured":"Jl P, Mm W, Jc P, et al. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab. 2000;85(12):4526\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"951_CR28","doi-asserted-by":"publisher","first-page":"8892","DOI":"10.1038\/s41598-022-12835-9","volume":"12","author":"PT Chen","year":"2022","unstructured":"Chen PT, Chang D, Liu KL, et al. Radiomics utilization to differentiate nonfunctional adenoma in essential hypertension and functional adenoma in primary aldosteronism. Sci Rep. 2022;12(1):8892.","journal-title":"Sci Rep"},{"key":"951_CR29","doi-asserted-by":"publisher","first-page":"634879","DOI":"10.3389\/fonc.2021.634879","volume":"11","author":"K He","year":"2021","unstructured":"He K, Zhang ZT, Wang ZH, et al. A clinical-radiomic nomogram based on unenhanced computed tomography for predicting the risk of aldosterone-producing adenoma. Front Oncol. 2021;11:634879.","journal-title":"Front Oncol"},{"issue":"1","key":"951_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13550-020-00686-2","volume":"10","author":"RM Martens","year":"2020","unstructured":"Martens RM, Koopman T, Noij DP, et al. Predictive value of quantitative (18)F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma. EJNMMI Res. 2020;10(1):102.","journal-title":"EJNMMI Res"},{"issue":"2","key":"951_CR31","doi-asserted-by":"publisher","first-page":"e88598","DOI":"10.1371\/journal.pone.0088598","volume":"9","author":"Y Chong","year":"2014","unstructured":"Chong Y, Kim JH, Lee HY, et al. Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: Are they different from those in neoadjuvant concurrent chemoradiotherapy? PLoS ONE. 2014;9(2):e88598.","journal-title":"PLoS ONE"},{"key":"951_CR32","doi-asserted-by":"publisher","first-page":"109874","DOI":"10.1016\/j.ejrad.2021.109874","volume":"142","author":"D Caruso","year":"2021","unstructured":"Caruso D, Zerunian M, Daffina J, et al. Radiomics and functional imaging in lung cancer: the importance of radiological heterogeneity beyond FDG PET\/CT and lung biopsy. Eur J Radiol. 2021;142:109874.","journal-title":"Eur J Radiol"},{"issue":"8","key":"951_CR33","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s00259-022-05742-8","volume":"49","author":"K Sun","year":"2022","unstructured":"Sun K, Shi L, Qiu J, et al. Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions. Eur J Nucl Med Mol Imaging. 2022;49(8):2917\u201328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"951_CR34","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1007\/s00330-019-06585-y","volume":"30","author":"W Wang","year":"2020","unstructured":"Wang W, Gu D, Wei J, et al. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI. Eur Radiol. 2020;30(5):3004\u201314.","journal-title":"Eur Radiol"},{"issue":"1","key":"951_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12880-019-0321-9","volume":"19","author":"J Wu","year":"2019","unstructured":"Wu J, Liu A, Cui J, et al. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging. 2019;19(1):23.","journal-title":"BMC Med Imaging"},{"issue":"5","key":"951_CR36","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.21037\/jtd.2019.05.32","volume":"11","author":"H Sui","year":"2019","unstructured":"Sui H, Liu L, Li X, et al. CT-based radiomics features analysis for predicting the risk of anterior mediastinal lesions. J Thorac Dis. 2019;11(5):1809\u201318.","journal-title":"J Thorac Dis"},{"key":"951_CR37","doi-asserted-by":"publisher","first-page":"34921","DOI":"10.1038\/srep34921","volume":"6","author":"L He","year":"2016","unstructured":"He L, Huang Y, Ma Z, et al. Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep. 2016;6:34921.","journal-title":"Sci Rep"},{"issue":"3","key":"951_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/radiol.2021202553","volume":"298","author":"MR Tomaszewski","year":"2021","unstructured":"Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;298(3):505\u201316.","journal-title":"Radiology"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-022-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-022-00951-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-022-00951-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T22:05:38Z","timestamp":1673474738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-022-00951-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s12880-022-00951-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1954348\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,7]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of the Shandong Provincial Hospital Affiliated to Shandong First Medical University approved this retrospective study. All methods were carried out in accordance with relevant guidelines and regulations. Informed consent (written consent) was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients signed informed consent regarding publishing their clinical data and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}